A

AxoSim

28 employees

AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
organoids
3D Cell Assays
Neurodegenerative Disease Models
Preclinical Testing
Neuroefficacy
Myelination Models
Toxicology
Neurotoxicity
Neuroscience
Drug Developent
Medical
Biopharma
Nerve-on-a-Chip
Peripheral Neuropathy
Organ-on-a-Chip
Life Science

Date founded

2014

Funding rounds raised

Total raised

$1.8M

from 11 investors over 11 rounds

A

AxoSim raised undisclosed on May 28, 2021

Investors: New Orleans BioFund

A

AxoSim raised undisclosed on November 5, 2020

Investors: Benson Capital Partners

A

AxoSim raised undisclosed on June 1, 2019

Investors: New Orleans BioFund

A

AxoSim raised $1.1M on March 7, 2019

Investors: Great Stuff Ventures

A

AxoSim raised $200K on September 21, 2018

Investors: National Institutes of Health

A

AxoSim raised $665K on September 1, 2018

Investors: National Institutes of Health

A

AxoSim raised $1.8M on September 14, 2017

Investors: National Institutes of Health

A

AxoSim raised undisclosed on August 3, 2017

Investors: New Orleans BioFund

A

AxoSim raised undisclosed on April 1, 2017

Investors: Lagniappe Angels, Abstraction Ventures and New Orleans BioFund

FAQ